Compositions – Nonreactive analytical – testing – or indicating compositions
Patent
1978-11-16
1980-04-22
Marantz, Sidney
Compositions
Nonreactive analytical, testing, or indicating compositions
23230B, 23928, G01N 3316
Patent
active
041994710
ABSTRACT:
A freeze-stable liquid blood control standard and method is provided for the quality control of the measurement of blood pH and gases in the clinical laboratory. The blood control standard comprises a sealed receptacle containing specially treated red cells and a gaseous head space at least equal to about the volume of the red cells. The special treatment comprises thorough washing and separating the red cells from the plasma components and mild treatment with aldehyde, slow admixture with lower aliphatic diol or triol, and retention in a buffered solution. The special treatment optionally includes treating at least a portion of the red cells with carbon monoxide. The head space comprises from 0-15% CO.sub.2, 0-25% O.sub.2 and the balance N.sub.2 and/or inert gas.
REFERENCES:
patent: 3876375 (1975-04-01), Maurukas
patent: 3973913 (1976-08-01), Louderback
patent: 4056484 (1977-11-01), Heimburger
patent: 4116336 (1978-09-01), Sorensen
patent: 4121905 (1978-10-01), Maurukas
patent: 4126575 (1978-11-01), Louderback
Louderback Allan L.
Szatkowski Paul R.
LandOfFree
Freeze-stable liquid blood control standard does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Freeze-stable liquid blood control standard, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Freeze-stable liquid blood control standard will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1474549